HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel W Nebert Selected Research

Cytochrome P-450 CYP1A2 (CYP1A2)

3/2018Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.
11/2016Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
7/2013Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes.
9/2011In utero and lactational exposure to PCBs in mice: adult offspring show altered learning and memory depending on Cyp1a2 and Ahr genotypes.
1/2011In utero and lactational exposure to a complex mixture of polychlorinated biphenyls: toxicity in pups dependent on the Cyp1a2 and Ahr genotypes.
5/2009CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.
7/2006For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential.
5/2005Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse.
2/2005Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
2/2003Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel W Nebert Research Topics

Disease

28Neoplasms (Cancer)
03/2021 - 03/2002
9Inflammation (Inflammations)
03/2018 - 08/2009
9Carcinogenesis
10/2013 - 08/2003
6Necrosis
01/2019 - 03/2005
4Atrophy
12/2015 - 05/2004
4Body Weight (Weight, Body)
09/2014 - 11/2002
4Hepatocellular Carcinoma (Hepatoma)
05/2009 - 05/2002
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 10/2002
3Infections
07/2018 - 07/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2013 - 11/2010
3Adenocarcinoma
09/2013 - 11/2010
3Genetic Predisposition to Disease (Genetic Predisposition)
09/2011 - 09/2005
2Congenital Abnormalities (Deformity)
01/2019 - 07/2006
2Anemia
07/2018 - 01/2012
2Drug-Related Side Effects and Adverse Reactions
07/2017 - 11/2006
2Lung Injury
09/2014 - 02/2010
2Atherosclerosis
02/2014 - 10/2009
2Balkan Nephropathy (Balkan Endemic Nephropathy)
12/2012 - 10/2011
2Liver Diseases (Liver Disease)
12/2010 - 05/2007
2Cleft Palate (Palate, Cleft)
07/2006 - 02/2006
2Hydronephrosis
07/2006 - 02/2006
2Hypertrophy
04/2006 - 05/2004
2Coronary Disease (Coronary Heart Disease)
05/2005 - 11/2002
2Porphyria Cutanea Tarda
02/2003 - 04/2002
1Seizures (Absence Seizure)
02/2023
1COVID-19
12/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019
1Parkinson Disease (Parkinson's Disease)
01/2019
1Osteoarthritis
01/2019
1Leigh Disease (Leigh's Disease)
01/2019
1Hypotension (Low Blood Pressure)
01/2019
1Hypersensitivity (Allergy)
01/2019
1Myopia
01/2019
1Ischemic Stroke
01/2019
1Schizophrenia (Dementia Praecox)
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Scoliosis
01/2019
1Crohn Disease (Crohn's Disease)
01/2019
1Growth Disorders
07/2018
1Hypoxia (Hypoxemia)
07/2018
1Non-alcoholic Fatty Liver Disease
03/2018
1Squamous Cell Carcinoma of Head and Neck
11/2016
1Intellectual Disability (Idiocy)
12/2015
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
12/2015
1Fanconi Anemia (Fanconi's Anemia)
11/2015
1Hyperoxia
09/2014

Drug/Important Bio-Agent (IBA)

19Cytochrome P-450 CYP1A1 (CYP1A1)IBA
03/2018 - 11/2002
14Cytochrome P-450 CYP1A2 (CYP1A2)IBA
03/2018 - 04/2002
10EnzymesIBA
09/2014 - 05/2004
7Proteins (Proteins, Gene)FDA Link
03/2021 - 05/2009
7Messenger RNA (mRNA)IBA
07/2018 - 11/2002
7Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2018 - 05/2004
7Benzo(a)pyreneIBA
03/2018 - 05/2004
6Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
07/2013 - 06/2004
6DNA (Deoxyribonucleic Acid)IBA
12/2006 - 10/2002
5LipidsIBA
09/2014 - 11/2002
4Glutathione (Reduced Glutathione)IBA
02/2023 - 05/2007
4CadmiumIBA
01/2019 - 03/2005
4Cytochrome P450 Family 1IBA
09/2013 - 06/2004
4Polychlorinated Dibenzodioxins (TCDD)IBA
07/2013 - 05/2004
4DioxinsIBA
05/2009 - 11/2002
3ManganeseIBA
12/2015 - 09/2008
3Prostaglandins DIBA
09/2013 - 11/2010
3aristolochic acid I (aristolochic acid)IBA
12/2012 - 10/2011
3IronIBA
01/2012 - 04/2002
3CarcinogensIBA
11/2010 - 08/2003
2CationsIBA
07/2018 - 08/2009
2SymportersIBA
07/2018 - 08/2009
2Bile Acids and Salts (Bile Acids)IBA
03/2018 - 02/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 02/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2014 - 02/2011
2SmokeIBA
02/2014 - 07/2013
2Environmental Pollutants (Pollutants, Environmental)IBA
02/2014 - 12/2002
2SerpinsIBA
10/2013 - 05/2013
2Mixed Function Oxygenases (Monooxygenases)IBA
09/2013 - 05/2009
2ZymosanIBA
09/2013 - 06/2008
2Polychlorinated Biphenyls (PCBs)IBA
09/2011 - 05/2005
2AntioxidantsIBA
12/2010 - 05/2007
2CytokinesIBA
10/2010 - 01/2010
2LigandsIBA
01/2010 - 05/2005
2methoxyresorufin-O-demethylaseIBA
05/2009 - 02/2003
2CytochromesIBA
03/2007 - 01/2005
2Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
04/2006 - 05/2004
2Triglycerides (Triacylglycerol)IBA
05/2005 - 11/2002
1Drinking WaterIBA
02/2023
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2023
1Protein Isoforms (Isoforms)IBA
03/2021
1AerosolsIBA
12/2020
1HDL CholesterolIBA
01/2019
1SeleniumIBA
10/2018
1Complement System Proteins (Complement)IBA
07/2018
1Bicarbonates (Hydrogen Carbonate)IBA
07/2018
1zinc-binding protein (zinc binding protein)IBA
12/2015
1Transferrin (beta 2 Transferrin)IBA
12/2015
1Fanconi Anemia Complementation Group ProteinsIBA
11/2015
1Oxygen (Dioxygen)IBA
09/2014
1Interleukin-6 (Interleukin 6)IBA
09/2014

Therapy/Procedure

5Drug Therapy (Chemotherapy)
07/2017 - 03/2002
2Therapeutics
07/2013 - 04/2009
1Precision Medicine
07/2017